Overview
News
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Backers
1
Y Combinator
Momentum
0/100
no fresh signals
Last sign of life
this month
a posting or a news item
Tractionpublic signals, read monthly
Web presence
top 10%
of 133.2M domains by links, Common Crawl
Backed byfrom the funds' portfolios and accelerator catalogs
Similar startupsby what they do, their industry and backers

A biotech company developing better medicines for patients with autoimmune and inflammatory diseases. Leveraging powerful insights into the…

A biotech company dedicated to developing transformative medicines for people with neurodegenerative diseases using cutting-edge science…

Draupnir Bio is developing new innovative therapies for patients.

Our Mission. Deliver medicines that transform the lives of patients with neurodegenerative diseases.

Better medicine, fast.. Partner with us.

Coultreon Biopharma is a clinical-stage biotech company developing next-generation precision medicines for immunology and autoimmune…
News
Finalists recognized in University's flagship venture competition
Eco-friendly, AI, medical, and other inventions earn funds for President's Innovation Challenge winners.
Read more
Report
Healey-Driscoll Administration and Massachusetts Life Sciences Center Announce Awardees for Public-Private Initiative to Support Diverse Entrepreneurs
Awardees represent first cohort of recently expanded MassNextGen Initiative Cambridge, MA-Today, Secretary of Economic Development Yvonne Hao joined the
Read more
Report

Y Combinator